Agilent Technologies, Inc. (NYSE:A) Given Average Recommendation of “Moderate Buy” by Brokerages

Agilent Technologies, Inc. (NYSE:A) has earned an average rating of “Moderate Buy” from the sixteen ratings firms that are presently covering the stock, Marketbeat reports. Three analysts have rated the stock with a hold rating, twelve have given a buy rating and one has assigned a strong buy rating to the company. The average 12 month target price among brokerages that have issued a report on the stock in the last year is $163.3077.

A has been the subject of several research reports. Wall Street Zen upgraded shares of Agilent Technologies from a “hold” rating to a “buy” rating in a research note on Friday, October 3rd. Rothschild Redb raised Agilent Technologies to a “strong-buy” rating in a report on Wednesday, October 8th. Citigroup lifted their target price on Agilent Technologies from $165.00 to $185.00 and gave the stock a “buy” rating in a report on Tuesday, November 25th. JPMorgan Chase & Co. increased their price target on shares of Agilent Technologies from $165.00 to $180.00 and gave the stock an “overweight” rating in a report on Tuesday, November 25th. Finally, TD Cowen boosted their target price on shares of Agilent Technologies from $150.00 to $162.00 and gave the company a “buy” rating in a research report on Tuesday, October 14th.

Agilent Technologies Stock Performance

Shares of Agilent Technologies stock opened at $139.68 on Monday. Agilent Technologies has a one year low of $96.43 and a one year high of $160.27. The company has a 50-day simple moving average of $144.41 and a two-hundred day simple moving average of $133.54. The company has a debt-to-equity ratio of 0.45, a quick ratio of 1.52 and a current ratio of 1.96. The company has a market capitalization of $39.60 billion, a PE ratio of 30.56, a P/E/G ratio of 4.05 and a beta of 1.29.

Agilent Technologies (NYSE:A) last released its quarterly earnings results on Monday, November 24th. The medical research company reported $1.59 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.58 by $0.01. Agilent Technologies had a net margin of 18.75% and a return on equity of 25.20%. The business had revenue of $1.86 billion for the quarter, compared to analyst estimates of $1.83 billion. During the same period in the previous year, the company earned $1.46 earnings per share. The business’s revenue for the quarter was up 9.4% on a year-over-year basis. Agilent Technologies has set its Q1 2026 guidance at 1.350-1.380 EPS and its FY 2026 guidance at 5.860-6.000 EPS. Research analysts expect that Agilent Technologies will post 5.58 EPS for the current fiscal year.

Agilent Technologies Increases Dividend

The business also recently declared a quarterly dividend, which will be paid on Wednesday, January 28th. Shareholders of record on Tuesday, January 6th will be issued a $0.255 dividend. The ex-dividend date of this dividend is Tuesday, January 6th. This is a boost from Agilent Technologies’s previous quarterly dividend of $0.25. This represents a $1.02 dividend on an annualized basis and a yield of 0.7%. Agilent Technologies’s dividend payout ratio is presently 22.32%.

Insider Activity at Agilent Technologies

In related news, VP Rodney Gonsalves sold 3,000 shares of the stock in a transaction on Wednesday, November 26th. The shares were sold at an average price of $154.99, for a total transaction of $464,970.00. Following the sale, the vice president directly owned 31,846 shares of the company’s stock, valued at approximately $4,935,811.54. This represents a 8.61% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available at this hyperlink. Also, CEO Padraig Mcdonnell sold 911 shares of Agilent Technologies stock in a transaction on Tuesday, November 18th. The shares were sold at an average price of $143.24, for a total transaction of $130,491.64. Following the completion of the transaction, the chief executive officer directly owned 32,058 shares of the company’s stock, valued at $4,591,987.92. The trade was a 2.76% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. In the last 90 days, insiders sold 16,401 shares of company stock worth $2,468,962.

Hedge Funds Weigh In On Agilent Technologies

A number of large investors have recently bought and sold shares of the business. Board of the Pension Protection Fund acquired a new position in shares of Agilent Technologies during the 4th quarter worth approximately $27,000. Capital A Wealth Management LLC increased its stake in shares of Agilent Technologies by 10,600.0% during the second quarter. Capital A Wealth Management LLC now owns 214 shares of the medical research company’s stock worth $25,000 after purchasing an additional 212 shares in the last quarter. Davis Capital Management acquired a new position in shares of Agilent Technologies during the 3rd quarter worth about $28,000. Physician Wealth Advisors Inc. boosted its holdings in Agilent Technologies by 490.0% in the 3rd quarter. Physician Wealth Advisors Inc. now owns 236 shares of the medical research company’s stock worth $30,000 after buying an additional 196 shares during the last quarter. Finally, State of Wyoming purchased a new position in shares of Agilent Technologies in the second quarter valued at approximately $35,000.

Agilent Technologies Company Profile

Agilent Technologies is a global provider of scientific instrumentation, consumables, software and services for laboratories across the life sciences, diagnostics and applied chemical markets. The company’s product portfolio includes analytical instruments such as liquid and gas chromatographs, mass spectrometers, spectroscopy systems, and laboratory automation solutions, together with reagents, supplies and informatics tools that support measurement, testing and data analysis workflows. Agilent also offers instrument maintenance, qualification and laboratory services designed to help customers improve productivity and comply with regulatory requirements.

Founded as a corporate spin-off from Hewlett‑Packard in 1999, Agilent has evolved through a combination of strategic restructuring and acquisitions to concentrate on life sciences, diagnostics and applied laboratories.